Announcements Trials
Browse Landscape

Status

Completed 5Active not recruiting 4Withdrawn 2Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Lung Neoplasms 1Hypoxia 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 224Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 194camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119toripalimab 118Radiosurgery 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108S 1 (combination) 105anlotinib 104Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × fluoroazomycin arabinoside × Clear all
NCT00765986 2014-10-03

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

AHS Cancer Control Alberta

Unknown
30 enrolled
Thoracic

Lung Neoplasms

NCT00388687 2006-10-17

Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer

Medical University of Vienna

Unknown
25 enrolled
Gynecologic

Hypoxia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡